ESSA Pharma to Present at 2022 Jefferies Healthcare Conference
ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company dedicated to prostate cancer therapies, is set to present at the 2022 Jefferies Healthcare Conference in New York City on June 9, 2022, at 3:00 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company dedicated to prostate cancer therapies, is set to present at the 2022 Jefferies Healthcare Conference in New York City on June 9, 2022, at 3:00 p.m. ET. David R. Parkinson, the President and CEO, along with CFO David S. Wood, will participate in one-on-one meetings during the event. The presentation will follow a fireside chat format and will be accessible via a webcast on the company's website. The archived webcast will be available for 90 days.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was +5.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, June 2, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2022 Jefferies Healthcare Conference in New York City on Thursday, June 9, 2022 at 3:00 p.m. Eastern Time.
David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings. David S. Wood, ESSA's Chief Financial Officer, will also be participating in the one-on-one meetings.
Presentation Details
Presentation Date: | Thursday, June 9, 2022 |
Presentation Time: | 3:00 p.m. ET |
Format: | Fireside Chat |
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
A webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the presentation, the webcast will be archived for 90 days.
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-2022-jefferies-healthcare-conference-301559630.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.